iGeneTech: Ten years of evolution, all for better target gene enrichment, founded in Beijing in 2014, is a biotechnology company. With intellectual property rights, there are three major technology platforms: NGS probe hybridization, multiplex PCR primer design, and high-throughput oligo pools synthesis. A high-tech enterprise certified by ISO 13485 and ISO 9001 quality management systems, that provides customized gene capture products for fields such as tumor companion diagnosis, multi-cancer early detection, breeding chips, pathogen monitoring, etc.
Design for Decoding
Integrity, efficiency, inclusiveness and responsibility
Innovative Gene-industry Turbo-engine
Precise, rigorous, thinking and innovation
Customers all around the world
Pre-designed target gene capture panels and reagent kits
High-standard customized target gene capture panels
Core raw materials for NGS-IVD application
iGeneTech Bioscience have a highly capable and experienced team. The core team of iGeneTech Bioscience has more than 15 years of gene capture related experience. By the end of May 2023, the R&D team has more than 50 researchers, most of the team members have acquired extensive study and work experience at renowned international scientific research institutions and related enterprises. Consequently, the team is well-equipped to provide robust support for product development, manufacturing, and after-sales service.
Experience in Target Sequencing
R&D Members
Patents
Software copyrights
Target enrichment technology based on hybradization-based capture
Methyl target enrichment technology based on hybradization-based capture
Target enrichment technology based on multiplex PCR